BPA Call W81K0222A0010-HT009026FG0170001
Award Date 1/12/26
Potential Completion Date 9/30/26
Potential Value $25K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
City of Industry, CA 91746, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency awarded a $35,818.34 firm fixed price call under an existing Blanket Purchase Agreement to Prolacta Bioscience, Inc. for the purchase of human milk-based nutritional products to support premature infants in the Neonatal Intensive Care Unit at Tripler Army Medical Center. The contract, which commenced on October 1, 2025, and extends through September 30, 2026, requires no set-aside designation. Prolacta Bioscience, headquartered in City of Industry, California,...
- The Defense Health Agency awarded a $24,246.50 firm fixed price Blanket Purchase Agreement (BPA) call contract to Prolacta Bioscience, Inc. on July 28, 2025, with completion scheduled for September 30, 2025. This task order is for the provision of Prolacta breastmilk products specifically designed for administration to critically ill and premature infants in neonatal intensive care units (NICUs). The contract carries no set-aside designation and will be performed at the contractor's facility...
- The Defense Health Agency awarded a purchase order valued at approximately $13,000 to Prolacta Bioscience, Inc. of Bassett, California under a Blanket Purchase Agreement call. This firm fixed price contract is for the delivery of breastmilk supplementation products to Tripler Army Medical Center in Hawaii through September 2023. Prolacta Bioscience will provide these products with no set-aside designation applied to the award. As the leading supplier of human milk-based nutritional products...
- This firm fixed price contract was awarded by the Defense Health Agency to Prolacta Bioscience, Inc. to provide Prolacta's proprietary human milk-based nutritional products for use with infants in the neonatal intensive care unit (NICU) at Tripler Army Medical Center. The $15,536.12 contract is a call against a larger $250,000 single-award blanket purchase agreement for donor human milk and a $1.75 million single-award BPA for various human milk-based products to support military treatment...
- The Defense Health Agency awarded a firm fixed price purchase order to Prolacta Bioscience, Inc. for $163,374.46 to provide human milk-based neonatal nutrition products. This award was not set aside for any special business category. Prolacta Bioscience is a private, for-profit manufacturer that supplies specialized breastmilk-derived formulas, supplements, and other nutritional therapies to support premature and critically ill infants treated at military medical facilities. The award is...
- The Department of the Army Medical Command awarded a firm fixed price blanket purchase agreement (BPA) call to Prolacta Bioscience, Inc., a manufacturer of human milk-based neonatal nutrition products. The $150,000 award provides specialized nutritional support for premature and critically ill infants treated at military medical facilities. Prolacta Bioscience supplies a range of human milk-derived items, including donor human milk, pre-natal formulas, food supplements, and breastmilk...
- This is a firm fixed price blanket purchase agreement (BPA) call contract awarded by the Defense Health Agency (DHA) to Prolacta Bioscience, Inc., a for-profit manufacturer of human milk-based nutritional products. The $24,037.95 contract is for the delivery of breastmilk products to support premature and critically ill infants in military medical facilities. Prolacta Bioscience has also been awarded three significant indefinite delivery vehicle (IDV) contracts by the DHA, valued at $1.75...
- Prolacta Bioscience, Inc., a for-profit manufacturer, was awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) call by the Defense Health Agency (DHA) to provide infant breast milk products in support of neonatal intensive care unit patients at military medical facilities. The potential value of this BPA call is $24,943.82, with a completion date of September 30, 2024. Prolacta Bioscience has held multiple previous contracts with the DHA and Department of the Army Medical Command to...
- This contract was awarded to Prolacta Bioscience, Inc. by the Department of the Army Medical Command. The contract, valued at $150,000.00, is for the provision of human milk-based neonatal nutrition products to support premature and critically ill infants treated at military medical facilities. The contract is a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing type, and a performance period ending on September 30, 2022. Prolacta Bioscience, a manufacturer of goods, has...
- This federal contract award to Prolacta Bioscience, Inc. is for PROLACT+6 HMF and PROLACTA NEONATAL FORMULA products. The $3,254,150.28 fixed-price contract was awarded on October 1, 2019 by the Defense Health Agency, a defense agency, and has an ultimate completion date of September 30, 2024. The contract does not have a set-aside designation. Prolacta Bioscience, a for-profit manufacturer of human milk-based nutritional products, is the prime contractor. The award is associated with three...